Vapor therapy for severe emphysema
Part of Lungs & breathing clinical trials.
This trial tests a treatment that uses heated water vapor to shrink damaged parts of the lungs in people with severe emphysema. The goal is to improve breathing and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old.
- You have emphysema that is worse in some parts of your lungs than others.
- Your lung function tests show severe airflow blockage but your lungs are not too overinflated.
- You can walk at least 140 meters (about 1.5 football fields) in 6 minutes.
- You have shortness of breath that limits your daily activities.
- You are willing to sign a consent form after learning about the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a bronchoscopy procedure that uses heat (thermoablation) to reduce over-inflated lung tissue in people with severe emphysema. If you qualify, it aims to improve breathing and walking ability after trying standard treatments first.
This study tests a new bronchoscopic treatment called BTVA for people with severe emphysema. It uses heat to shrink damaged parts of the lung to improve breathing.
This trial tests a procedure called Endobronchial Thermal Liquid Ablation (ETLA) that uses heated liquid to treat severe emphysema. It is for people with COPD who have very low lung function and shortness of breath, and who have not been able to get relief from other treatments.
This study follows people with uneven emphysema to better understand outcomes and safety after treatment. If you qualify, you’ll share health information and may undergo lung imaging before and after treatment.
This study tests a minimally invasive “vapor ablation” procedure that destroys small lung cancer spots. It may be an option if you were recommended surgery or an alternative to surgery instead.
This trial tests a cell-based treatment placed into the lung using an airway valve, to help people with severe emphysema breathe easier. You may be eligible if your emphysema is uneven in the lungs and testing suggests your “collateral ventilation” is low, meaning the treatment area may benefit more from blocking airflow.
Hear when a new Heterogeneous Emphysema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.